KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Non-Current Debt (2016 - 2026)

Medtronic (MDT) has disclosed Non-Current Debt for 13 consecutive years, with $27.9 billion as the latest value for Q1 2026.

  • Quarterly Non-Current Debt rose 16.24% to $27.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $27.9 billion through Jan 2026, up 16.24% year-over-year, with the annual reading at $25.6 billion for FY2025, 7.15% up from the prior year.
  • Non-Current Debt hit $27.9 billion in Q1 2026 for Medtronic, up from $27.7 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $27.9 billion in Q1 2026 to a low of $17.5 billion in Q3 2022.
  • Historically, Non-Current Debt has averaged $24.0 billion across 5 years, with a median of $24.3 billion in 2022.
  • Biggest five-year swings in Non-Current Debt: crashed 32.66% in 2022 and later skyrocketed 39.94% in 2023.
  • Year by year, Non-Current Debt stood at $20.8 billion in 2022, then rose by 14.4% to $23.7 billion in 2023, then grew by 3.65% to $24.6 billion in 2024, then grew by 12.49% to $27.7 billion in 2025, then increased by 0.72% to $27.9 billion in 2026.
  • Business Quant data shows Non-Current Debt for MDT at $27.9 billion in Q1 2026, $27.7 billion in Q4 2025, and $26.2 billion in Q3 2025.